Drug
TV 1106
TV 1106: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| TV-1106 NCT02410356 | Phase 3 | Growth Hormone Deficiency |
Latest
No recent events.
Follow TV 1106 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.